Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.6M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.01M
-
Shares change
-
+271K
-
Total reported value, excl. options
-
$6.22M
-
Value change
-
+$1.6M
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$5.90
Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q1 2021
14 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.01M shares
of 10.6M outstanding shares and own 9.55% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (423K shares), Roumell Asset Management, LLC (222K shares), VANGUARD GROUP INC (150K shares), Worth Venture Partners, LLC (105K shares), Minot Wealth Management LLC (72.2K shares), BlackRock Inc. (26.4K shares), PERRITT CAPITAL MANAGEMENT INC (10.1K shares), Financial Perspectives, Inc (1.48K shares), WELLS FARGO & COMPANY/MN (1.23K shares), and CITIGROUP INC (750 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.